MAN & SCIENCE
The computed 12-month bankruptcy probability of MAN & SCIENCE is 0.3% (very low). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 15 yrs |
| Board | 6 |
| Locations | 1 |
| Publications | 17 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 10-10-2025 | 2025-00542273 |
| 31-12-2023 | micro | 31-01-2025 | 2025-00020118 |
| 31-12-2022 | micro | 31-08-2023 | 2023-00424240 |
| 31-12-2021 | micro | 06-05-2022 | 2022-20023790 |
| 31-12-2020 | micro | 11-06-2021 | 2021-19500233 |
| 31-12-2019 | volledig | 31-07-2020 | 2020-38200276 |
| 31-12-2018 | micro | 31-10-2019 | 2019-73200444 |
| 31-12-2017 | micro | 31-08-2018 | 2018-61000324 |
| 31-12-2016 | micro | 31-07-2017 | 2017-39600155 |
| 31-12-2015 | volledig | 28-09-2016 | 2016-63200218 |
-
Biotech Management & ConsultingLegal entityManaging director· perm. rep.: Hugues WallemacqState Gazette act 25126302 (06-10-2025)Current25-07-2025 → present
-
Current01-07-2025 → present
-
Current20-05-2025 → present
-
SC Noshaq PartnersLegal entityDirector· perm. rep.: Marc FoidartState Gazette act 21057394 (12-05-2021)Current17-03-2021 → present
2 events
- 17-03-2021 Resigned· Director
- 17-03-2021 Appointed· Director
-
Current16-12-2020 → present
2 events
- 20-05-2025 Mandate renewed· Director
- 16-12-2020 Appointed· Director
-
Current20-06-2016 → present
2 events
- 20-05-2025 Mandate renewed· Director
- 20-06-2016 Mandate renewed· Director
Historic, not recently confirmed (1)
-
Not recently confirmedlast confirmed in an act from 2016
Former directors (3)
-
Former16-05-2024 → 20-05-2025
2 events
- 20-05-2025 Resigned· Director
- 16-05-2024 Appointed· Director
-
Former- → 16-05-2024
-
Former- → 20-06-2016
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| SRL REWISECurrent Company auditor · represented by Pascal CELEN |
- | 15-09-2020 → present |
| NACE primary | Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden(32500) |
| Legal form | Public limited company(014) |
| Incorporation | 29-06-2011 |
| Status | Active |
| Postal code | 4000 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62042B0366/00B003 | Wallonia | 1.9 ha | - | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
11-03-2026 Capital increase
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 28167146.56,
"delta_eur": 5286737.75,
"before_eur": 22880772.81,
"subscribers": [
{
"kbo": "0894.734.532",
"rrn": null,
"kind": "org",
"name": "ROBELGA",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "numeraire",
"n_shares_subscribed": 50573,
"contribution_amount_eur": 2354979.92
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "JH Capital GmbH",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "numeraire",
"n_shares_subscribed": 24639,
"contribution_amount_eur": 1147344.62
}
],
"share_emission": {
"agio_eur": 778426.25,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 130241,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 46.57
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"_arith_inconsistent": true,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 28945572.81,
"delta_eur": 778426.25,
"before_eur": 28167146.56,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Sibylle FALLA",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2026-03-11",
"filing_date": "2026-03-09",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2026-02-19",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": null,
"individual_name": null
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition conforme de l\u0027acte",
"Liste de pr\u00E9sence",
"statuts coordonn\u00E9s"
],
"shareholders_after": [
{
"kbo": "0894.734.532",
"pct": null,
"kind": "org",
"name": "ROBELGA",
"role": null,
"n_shares": 50573,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "JH Capital GmbH",
"role": null,
"n_shares": 24639,
"share_class": null
}
],
"share_classes_after": []
}06-10-2025 2 directors appointed, 2 resigning, 3 reappointed
- Gèry Lefebvre, Bestuurder
- Hugues Wallemacq, Gedelegeerd bestuurder
- NOSHAQ PARTNERS SRL, Bestuurder
- Olivier Taelman, Bestuurder
- Robert Taub, Bestuurder
- Jürgen Hambrecht, Bestuurder
- Anneliese Monden, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "NOSHAQ PARTNERS SRL",
"address": null,
"birth_date": null
},
"effective_date": "2025-07-25",
"evidence_quote": "l\u0027assembl\u00E9e r\u00E9voque le mandat d\u0027administrateur de NOSHAQ PARTNERS SRL dont le si\u00E8ge est \u00E9tabli Rue Lambert-Lombard 3 \u00E0 4000 Li\u00E8ge et inscrite \u00E0 la Banque-Carrefour des Entreprises sous le num\u00E9ro 0808.219.836, administrateur d\u00E9missionnaire qui avait \u00E9t\u00E9 nomm\u00E9 sur proposition des actionnaires institut",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "G\u00E8ry Lefebvre",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0452116307",
"name": "SPARAXIS SA",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-07-01",
"evidence_quote": "l\u0027assembl\u00E9e nomme en remplacement de NOSHAQ PARTNERS SRL, administrateur d\u00E9missionnaire qui avait \u00E9t\u00E9 nomm\u00E9 sur proposition des actionnaires institutionnels, \u00E0 savoir WALLONIE ENTREPRENDRE SA, NOSHAQ SA et NOSHAQ SPIN-OFFS SA, SPARAXIS SA dont le si\u00E8ge est \u00E9tabli Avenue Maurice-Destenay 13 \u00E0 4000 Li"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Robert Taub",
"address": null,
"birth_date": null
},
"effective_date": "2025-05-20",
"evidence_quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale proc\u00E8de au renouvellement des mandats des administrateurs suivant avec effet au 20 mai 2025 et ce jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de 2031 qui se prononcera sur l\u0027approbation des comptes annuels arr\u00EAt\u00E9s au 31 d\u00E9cembre 2030: (i)Monsieur Robert Taub;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "J\u00FCrgen Hambrecht",
"address": null,
"birth_date": null
},
"effective_date": "2025-05-20",
"evidence_quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale proc\u00E8de au renouvellement des mandats des administrateurs suivant avec effet au 20 mai 2025 et ce jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de 2031 qui se prononcera sur l\u0027approbation des comptes annuels arr\u00EAt\u00E9s au 31 d\u00E9cembre 2030: (ii)Monsieur J\u00FCrgen Hambrecht:"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Anneliese Monden",
"address": null,
"birth_date": null
},
"effective_date": "2025-05-20",
"evidence_quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale proc\u00E8de au renouvellement des mandats des administrateurs suivant avec effet au 20 mai 2025 et ce jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de 2031 qui se prononcera sur l\u0027approbation des comptes annuels arr\u00EAt\u00E9s au 31 d\u00E9cembre 2030: (iii)Madame ApDeliese Monden_"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Olivier Taelman",
"address": null,
"birth_date": null
},
"effective_date": "2025-05-20",
"evidence_quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de ne pas renouveler le mandat d\u0027administrateur de Monsieur Olivier Taelman ayant pris fin le 20 mai 2025."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Hugues Wallemacq",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0741644479",
"name": "BIOTECH MANAGEMENT \u0026 CONSULTING SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-07-25",
"evidence_quote": "le conseil d\u0027administration d\u00E9cide de remplacer OCTAVIAN SRL, dont le si\u00E8ge est \u00E9tabli Route d\u0027Ohain 44 \u00E0 1380 Lasne et inscrite \u00E0 la Banque-Carrefour des Entreprises sous le num\u00E9ro 0771.811.479, repr\u00E9sent\u00E8e par Monsieur Olivier M\u00E9nage (repr\u00E9sentant permanent et actuel CEO de la soci\u00E9t\u00E9) par BIOTECH"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}31-12-2024 Capital increase of €4,531,701.99 to €22,162,474.80
- €17.630.772,81 → €22.162.474,80
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 4531701.99,
"currency": "EUR",
"after_eur": 22162474.8,
"delta_eur": 4531701.99,
"before_eur": 17630772.81,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-12-26",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter le capital \u00E0 concurrence de quatre millions cinq cent trente et un mille sept cent et un euros et nonante-neuf cents (4.531.701,99 \u20AC) pour le porter de dix-sept millions six cent trente mille sept cent septante-deux euros et quatre-vingt-un cents (17.630.772,81 \u20AC) \u00E0 vingt-deux millions cent soixante-deux mille quatre cent septante-quatre euros et quatre-vingt cents (22.162.474,80 \u20AC) par apports en num\u00E9raire",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 718298.01,
"currency": "EUR",
"after_eur": 22880772.81,
"delta_eur": 718298.01,
"before_eur": 22162474.8,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-12-26",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de sept cent dix-huit mille deux cent nonante-huit euros et un cent (718.298,01 \u20AC) pour le porter de vingt-deux millions cent soixante-deux mille quatre cent septante-quatre euros et quatre-vingt cents (22.162.474,80 \u20AC) \u00E0 vingt-deux millions huit cent quatre-vingt mille sept cent septante-deux euros et quatre-vingt-un cents (22.880.772,81 \u20AC), sans cr\u00E9ation de nouvelles actions, par incorporation au capital de la totalit\u00E9 de la \u0022prime d\u0027\u00E9mission\u0022",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}14-11-2024 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}16-05-2024 1 director appointed, 1 resigning
- Olivier TAELMAN, Bestuurder
- Lars LUND-ROLAND, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lars LUND-ROLAND",
"address": null,
"birth_date": null
},
"evidence_quote": "DECIDE de coopter Monsieur Olivier TAELMAN en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 en remplacement de Monsieur Lars LUND-ROLAND."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Olivier TAELMAN",
"address": null,
"birth_date": null
},
"evidence_quote": "DECIDE de coopter Monsieur Olivier TAELMAN en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 en remplacement de Monsieur Lars LUND-ROLAND."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}23-02-2023 Capital increase of €4,510,425.18 to €17,630,772.81
- €13.120.347,63 → €17.630.772,81
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 2855768.63,
"currency": "EUR",
"after_eur": 13120347.63,
"delta_eur": 2855768.63,
"before_eur": 10264579,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-20",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de deux millions huit cent cinquante-cinq mille sept cent soixante-huit euros et soixante-trois centimes (2.855.768,63 \u20AC) pour le porter de dix millions deux cent soixante-quatre mille cinq cent septante-neuf euros (10.264.579 \u20AC), \u00E0 treize millions cent vingt mille trois cent quarante-sept euros soixante-trois centimes (13.120.347,63 \u20AC) ... par apport par les actionnaires actuels, de cr\u00E9ances certaines, liquides et exigibles qu\u2019ils d\u00E9tiennent sur la soci\u00E9t\u00E9",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 4510425.18,
"currency": "EUR",
"after_eur": 17630772.81,
"delta_eur": 4510425.18,
"before_eur": 13120347.63,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-20",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter le capital \u00E0 concurrence de quatre millions cinq cent dix mille quatre cent vingt-cinq euros et dix-huit centimes (4.510.425,18 \u20AC) pour le porter de treize millions cent vingt mille trois cent quarante-sept euros et soixante-trois centimes (13.120.347,63 \u20AC), \u00E0 dix-sept millions six cent trente mille sept cent septante-deux euros et quatre-vingt et un centimes (17.630.772,81\u20AC) par apports en num\u00E9raire",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}25-08-2022 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}30-05-2022 Capital increase of €7,647,723 to €10,264,579
- €2.616.856 → €10.264.579
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 7647723.0,
"currency": "EUR",
"after_eur": 10264579.0,
"delta_eur": 7647723.0,
"before_eur": 2616856.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-05-20",
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u2019augmenter le capital \u00E0 concurrence de sept millions six cent quarante-sept mille sept cent vingt-trois euros (\u20AC 7.647.723,00) pour porter le capital de deux millions six cent seize mille huit cent cinquante-six euros (\u20AC 2.616.856,00) \u00E0 dix millions deux cent soixante-quatre mille cinq cent septante-neuf euros (\u20AC 10.264.579,00) par la cr\u00E9ation de cent quinze mille six cent vingt-six (115.626) actions nouvelles",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}09-03-2022 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}12-05-2021 1 director appointed, 1 resigning
- Hugues Wallemacq, Bestuurder
- Marc Foidart, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc Foidart",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SC Noshaq Partners",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2021-03-17",
"evidence_quote": "L\u0027assembl\u00E9e accepte la d\u00E9mission de Monsieur Marc Foidart de sa fonction de repr\u00E9sentant permanent de la SC Noshaq Partners et ce, avec effet r\u00E9troactif au 17 mars 2021."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Hugues Wallemacq",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SC Noshaq Partners",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2021-03-17",
"evidence_quote": "Subs\u00E9quemment \u00E0 la d\u00E9mission susmentionn\u00E9e, l\u0027assembl\u00E9e nomme, en qualit\u00E9 de repr\u00E9sentant permanent de la SC Noshaq Partners, Monsieur Hugues Wallemacq, domicili\u00E9 \u00E0 B-4458 Fexhe-Slins, Rue Neuve 31 et ce, \u00E0 compter du 17 mars 2021."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}24-02-2021 Anneliese Monden appointed as director
- Anneliese Monden, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Anneliese Monden",
"address": null,
"birth_date": null
},
"effective_date": "2020-12-16",
"evidence_quote": "L\u0027assembl\u00E9e nomme, en qualit\u00E9 d\u0027administrateur de la soci\u00E9t\u00E9, Madame Anneliese Monden, domicili\u00E9e \u00E0 2950 Kapellen, Bloemenlei 1."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}29-09-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2020-09-15",
"legal_form_change": false
},
"bedrijfsrevisor": {
"quote": "l\u2019assembl\u00E9e dispense Monsieur le Pr\u00E9sident de donner lecture des rapports de l\u2019organe d\u2019administration et du r\u00E9viseur d\u2019entreprises, REWISE SRL, dont les bureaux sont situ\u00E9s \u00E0 4020 Li\u00E8ge, rue des Vennes, 151, repr\u00E9sent\u00E9e par Monsieur Pascal CELEN",
"firm_kbo": null,
"firm_name": "REWISE SRL",
"ibr_number": null,
"individual_name": "Pascal CELEN"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}04-06-2020 Registered office moved from Uccle to Mont-saint-Guibert
- Avenue Blücher 63, 1180 Uccle → rue Emile Francqui 9, 1435 Mont-saint-Guibert
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Mont-saint-Guibert",
"region": "Vlaams Gewest",
"street": "rue Emile Francqui",
"country": "BE",
"postcode": "1435",
"box_number": null,
"street_number": "9"
},
"old_address": {
"city": "Uccle",
"region": "Brussels Gewest",
"street": "Avenue Bl\u00FCcher",
"country": "BE",
"postcode": "1180",
"box_number": null,
"street_number": "63"
},
"effective_date": "2020-02-10",
"evidence_quote": "le transfert du si\u00E8ge de l\u0027entreprise vers l\u0027adresse 9 rue Emile Francqui \u00E0 1435 Mont-saint-Guibert, \u00E0 partir du 10 f\u00E9vrier 2020."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "MAN \u0026 SCIENCE",
"legal_form": "SA"
}
}08-01-2019 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "CEPHALIX",
"legal_form": "SA"
}
}07-02-2017 Registered office moved from Mont-Saint-Guibert to Bruxelles
- Rue Du Fond Cattelain 2, 1435 Mont-Saint-Guibert → Avenue Blücher 63, 1180 Bruxelles
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Bruxelles",
"region": "Brussels Gewest",
"street": "Avenue Bl\u00FCcher",
"country": "BE",
"postcode": "1180",
"box_number": null,
"street_number": "63"
},
"old_address": {
"city": "Mont-Saint-Guibert",
"region": "Waals",
"street": "Rue Du Fond Cattelain",
"country": "BE",
"postcode": "1435",
"box_number": null,
"street_number": "2"
},
"effective_date": "2017-01-01",
"evidence_quote": "Le conseil d\u0027administration d\u00E9cide du transfert du si\u00E8ge social au 01er janvier 2017 vers l\u0027Avenue Bl\u00FCcher 63 -1180 Bruxelles."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "CEPHALIX",
"legal_form": "SA"
}
}20-06-2016 1 resigning, 2 reappointed
- MASHIACH ADI, Bestuurder
- Robert TAUB, Bestuurder
- Uwe WASCHER, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Robert TAUB",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale renouvelle le mandant d\u0027administrateurs de : Monsieur Robert TAUB"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Uwe WASCHER",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale renouvelle le mandant d\u0027administrateurs de : Monsieur Uwe WASCHER"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "MASHIACH ADI",
"address": null,
"birth_date": null
},
"evidence_quote": "Le mandat de MASHIACH ADI n\u0027est pas reconduit."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0837.403.770",
"name_full": "CEPHALIX",
"legal_form": "SA"
}
}01-07-2011 Incorporation of a new SNC
Technical details
{
"kind": "oprichting",
"seat": "1435 Mont-Saint-Guibert, Rue du Fond Cattelain 2",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Robert TAUB",
"niss": null,
"address": "1180 Uccle, avenue des Eglantiers 37"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 62000,
"holder_person_name": "Robert TAUB",
"is_subscriber_only": false,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 62000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Uwe Siegfried WASCHER",
"niss": null,
"address": "2950 Kapellen, Bloemenlei 1"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": null,
"amount_paid_in_eur": 0,
"holder_person_name": "Uwe Siegfried WASCHER",
"is_subscriber_only": false,
"n_shares_subscribed": 0,
"amount_subscribed_eur": 0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 62000,
"subject_company": {
"kbo": "0837.403.770",
"name_full": "CEPHALIX",
"legal_form": "SNC"
},
"initial_directors": [],
"incorporation_date": "2011-06-28",
"post_incorporation_mandates": []
}| Legal nameFR | MAN & SCIENCE |